Related Experiment Video

Updated: Jun 12, 2025

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
05:30

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

330

The biology of exosomes and exosomal non-coding RNAs in cardiovascular diseases

Lu Gan1, Xiaofei Guo2, Shichao Dong3

  • 1Department of Pharmacy, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

Frontiers in Pharmacology
|June 10, 2025
PubMed

Insights

Exosomes, tiny vesicles carrying non-coding RNAs, show promise for treating cardiovascular diseases (CVDs). This review explores their mechanisms and potential in CVD therapy, offering insights into future treatments.

Area of Science:

  • Biomedical research
  • Molecular biology
  • Cardiology

Background:

  • Cardiovascular diseases (CVDs) are a leading global cause of mortality.
  • Current CVD treatments face limitations due to poor prognosis and cardiac remodeling.
  • Novel therapeutic mechanisms for CVDs require further investigation.

Purpose of the Study:

  • To review the physiological mechanisms of exosomes.
  • To summarize research on exosome-mediated regulation of CVDs using non-coding RNAs.
  • To discuss the therapeutic potential and challenges of exosomes in CVD treatment.

Main Methods:

  • Literature review of exosome physiology.
  • Analysis of studies on exosomal non-coding RNAs in cardiovascular research.
  • Synthesis of current findings on exosome-based CVD therapies.

Main Results:

  • Exosomes play crucial roles in intercellular communication.
  • Exosomal non-coding RNAs are key mediators in regulating CVD pathogenesis.
  • Significant progress has been made in understanding exosome functions in cardiovascular conditions.

Conclusions:

  • Exosomes represent a promising therapeutic avenue for cardiovascular diseases.
  • Targeting exosomal non-coding RNAs offers a novel strategy for CVD intervention.
  • Further research is needed to overcome limitations and realize the clinical potential of exosome-based therapies.

Keywords:
biomarkercardiovascular diseasesexosomesintercellular delivery systemsnon-coding RNAs

More Related Videos

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.0K
Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury08:27

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury

Published on: May 21, 2018

10.9K

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
63
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3